Avricore Health (AVCRF) Income from Continuing Operations (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Income from Continuing Operations of 174490.3 for Q2 2026, up 48.57% year-over-year from 117445.86 in Q2 2025, and up 45.67% quarter-over-quarter from 321177.93 in Q4 2025.
Avricore Health (AVCRF) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Income from Continuing Operations for 18 consecutive years, with 174490.3 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 48.57% year-over-year to 174490.3; the TTM figure through Jun 2026 stood at 1109797.83 (down 199.32% YoY), while the FY2025 annual figure was 1330411.62, down 172.26% from the prior year.
- Income from Continuing Operations advanced to 174490.3 in Q2 2026 per AVCRF's latest filing, from 321177.93 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 156564.9 in Q2 2024 and bottomed at 339282.82 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 135284.51 across 5 years, with a median of 154930.29 in 2022.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 1514.8% — and 2024, when it surged 180.58%.
- Avricore Health's Income from Continuing Operations stood at 174323.07 in 2022, then surged by 129.31% to 51100.9 in 2023, then sank by 365.59% to 135717.27 in 2024, then sank by 136.65% to 321177.93 in 2025, then jumped by 45.67% to 174490.3 in 2026.
- Business Quant data shows AVCRF's Income from Continuing Operations at 174490.3 in Q2 2026, 321177.93 in Q4 2025, and 274846.78 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | -174,490.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -174,490.30 |
| Dec 31, 2025 | -321,177.93 |
| Sep 30, 2025 | -274,846.78 |
| Jun 30, 2025 | -339,282.82 |
| Mar 31, 2025 | -52,333.55 |
| Sep 30, 2024 | -135,717.27 |
| Jun 30, 2024 | 156,564.90 |
| Mar 31, 2024 | 115,204.91 |
| Dec 31, 2023 | 51,100.90 |
| Sep 30, 2023 | -212,210.51 |
| Jun 30, 2023 | -211,529.47 |
| Mar 31, 2023 | -142,972.21 |
| Dec 31, 2022 | -174,323.07 |
| Sep 30, 2022 | -138,678.33 |
| Jun 30, 2022 | -163,137.37 |
| Mar 31, 2022 | -146,723.21 |
| Dec 31, 2021 | -105,615.25 |
| Sep 30, 2021 | -25,635.59 |
| Jun 30, 2021 | -39,746.50 |
| Mar 31, 2021 | -9,086.14 |